Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TDF Rollover Study in Chronic Hepatitis B
NCT02463019Phase 4Unknown
- Sponsor
- E-Da Hospital
- Start
- Jan 2015
- Primary completion
- Jan 2019
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB), sponsored by E-Da Hospital. Status: unknown.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT02463019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02463019.